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DObjective: The optimal shunt size for patients who have the Norwood operation with a right ventricle-to-
pulmonary artery conduit is controversial. The goal of this study is to compare outcomes of 2 shunt sizes in
this population.
Methods: Between 2002 and 2010, 75 consecutive patients diagnosed with hypoplastic left heart syndrome and
its variants underwent the Norwood procedure with a right ventricle-to-pulmonary artery conduit. The outcomes
of 20 neonates weighing<3 kg were analyzed.
Results: The cumulative 30-day stage 1 mortality was 97% (95% confidence interval, 88%-99%) for all pa-
tients (73/75), 20 of whom weighed<3 kg. Nine patients had a 6-mm (group 1) and 11 patients had a 5-mm
(group 2) right ventricle–to-pulmonary artery conduit. Thirty-day stage 1 survival was 88% (8/9) in group 1
and 90% (10/11) in group 2 (P ¼ .88). The central pulmonary artery confluence size at prebidirectional cavo-
pulmonary shunt catheterization was 4.5 1.2 mm in group 1 and 2.5 1.0 mm in group 2 (P¼ .009). Themean
transpulmonary gradient was higher in group 2 (7.8 3.1 mmHg vs 4.2 1.9 mmHg; P¼ .036). The incidence
of pulmonary artery intervention was 16% (1/7) in group 1 and 75% (6/8) in group 2 (P¼ .030). Survival rate at
6 months was 66% (6/9) in group 1 and 70% (7/10) in group 2 (P ¼ .89).
Conclusions: Use of a 6-mm right ventricle-to-pulmonary artery conduit showed better central pulmonary
artery growth and less need for pulmonary artery intervention in the authors’ experience. (J Thorac Car-
diovasc Surg 2012;144:1091-4)The most successful palliation for hypoplastic left heart
syndrome (HLHS) has been the Norwood procedure, first
introduced in 1983.1 The Norwood procedure has under-
gone several modifications and the outcomes of stage 1 pal-
liation have improved significantly during the past few
decades. Since Sano and colleagues2 reported the use of
the right ventricle–pulmonary artery (RV-PA) conduit, there
has been much debate about its benefits and potential disad-
vantages. The main advantage of the RV-PA conduit is de-
creased diastolic runoff into the pulmonary vasculature.
The higher systemic diastolic pressure compared with the
modified Blalock–Taussig shunt (mBTS) results in im-
proved myocardial perfusion with lower volume load-
ing.3-7 The physiology with the RV-PA conduit results in
more stable, immediate postoperative hemodynamics8-11
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The Journal of Thoracic and CarNorwood procedure showed that after randomization,
transplantation-free survival at 12 months was higher with
the RV-PA conduit than with the mBTS.12 However, some
reported disadvantages of the RV-PA conduit include in-
creased incidence of ventricular dysfunction, shunt steno-
sis, and central pulmonary artery (PA) stenosis.13-17
Moreover, precise evaluation of the affect of different RV-
PA conduit sizes has not been done. We hypothesized that
a 6-mm RV-PA conduit provided better PA growth, resolu-
tion of the problem, and satisfactory mid-term outcome
compared with a 5-mm conduit. The purpose of this study
was to identify the differences in surgical results, PA size,
and the incidence of PA intervention after the stage 1 Nor-
wood procedure with a 6-mm versus a 5-m RV-PA conduit




We performed a retrospective case–control study including all patients
who had the Norwood procedure using an RV-PA conduit between April
2002 and December 2010 at our institution. The study was approved and
monitored by the institutional review board and, because of its retrospective
nature, the need for patient consent was waived.We analyzed the outcomes
of stage 1 and stage 2 palliation in 20 neonates weighing<3 kg with HLHS
or one of its variants. Patientswere divided into either the 6-mmshunt group
(group 1) or the 5-mm shunt group (group 2) on the basis of which size of an
RV-PA conduit was placed at the time of the stage 1 reconstruction. Thediovascular Surgery c Volume 144, Number 5 1091
Abbreviations and Acronyms
BCPS ¼ bidirectional cavopulmonary shunt
HLHS ¼ hypoplastic left heart syndrome
mBTS ¼ modified Blalock–Taussig shunt
PA ¼ pulmonary artery
RV-PA ¼ right ventricle–pulmonary artery
SVC ¼ superior vena cava
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Dchoice of shunt was at the discretion of the surgeon. The transition from the
5-mm RV-PA conduit to the 6-mm was in 2008. The primary study popula-
tion comprised the total number of patientswith pre-Glenn cardiac catheter-
ization data available for analysis at our institution. Preoperative
demographics and surgical data were compared for our study population.
Surgical morbidity and mortality data through completion of the Glenn
procedure were collected at follow-up.
Medical records were reviewed and the following data were retrieved
and analyzed: basic demographic data; clinical presentation and past med-
ical and surgical history; perioperative data, including associated surgical
procedures; postoperative outcomes, including stage 1 Norwood procedure
and stage 2 bidirectional cavopulmonary shunt (BCPS); echocardiographic
data before stage 1 palliation, at hospital discharge, and before stage 2 pal-
liation; and catheterization data before stage 2 palliation.
Surgical Procedure
Norwood procedure with RV-PA conduit. The stage 1 recon-
struction for each patient was performed by the same surgeon. The standard
Norwood procedure performed at our institution during the study period
consisted of division of the main PA with side-to-side anastomosis to the
ascending aorta, or homograft patch augmentation of the ascending aorta
and aortic arch, with an RV-PA conduit, with atrial septectomy under selec-
tive cerebral perfusion. The final step involved the placement of a polytetra-
fluoroethylene conduit from the left side of the right ventricle infundibulum
just below the pulmonary valve to the central PA. The RV-PA conduit was
typically placed to the left of the neoaorta and anastomosed directly to the
glutaraldehyde-fixed pericardium patch on the PA bifurcation. No valved or
ringed polytetrafluoroethylene grafts were used.
Off-pump BCPS. After repeat sternotomy, a test occlusion of the
right PAwas then performed. If hemoglobin–oxygen saturations remained
70%, then the off-pump BCPS18 was performed. The superior vena cava
(SVC)–innominate vein junction and right atrial appendage were cannu-
lated with 12-Fr Pacifico cannulas (DLP Inc, Grand Rapids, Mich) and
were joined for insertion of a passive venous shunt. The SVC–right atrial
junction was clamped and divided, and the cardiac end was oversewn
with polypropylene sutures. The end of the SVC was sewn to the PA
with running fine polypropylene sutures after proximal and distal control
of the right PA was achieved. The azygous vein was ligated. The RV-PA
conduit was then clipped and divided.
Catheterization Analysis
Pre-Glenn cardiac catheterizations performed at our institution were re-
viewed. The diameters of the right and left PAsweremeasured just proximal
to the origin of the first-order PA branches and were used to calculate a Na-
kata index (combined right PA and left PA cross-sectional area indexed to
body surface area). Shunt stenosis was defined as>50% narrowing of the
shunt diameter. All measurements were corrected on the Vericis system
(Camtronics Medical Systems, Hartland, Wis) and calibrated to known
catheter or shunt diameter. The transpulmonary gradient wasmean PA pres-
sure less themean left atrium pressure. Coronary perfusion pressurewas the
pressure gradient between the right atrial and aortic diastolic pressures.1092 The Journal of Thoracic and Cardiovascular SurStatistical Analysis
Demographic data, operative factors, and postoperative events were re-
corded. Continuous variables are presented as mean ( standard deviation)
for normally distributed data. For subgroup analyses, the Student t test was
used to compare the parametric values; the Mann-WhitneyU test was used
to compare the nonparametric values. The 30-day survival, interstage mor-
tality, and PA intervention rate were computed using the c2 test as categor-
ical data. A probability value <.05 was considered significant for all
analyses. Analysis was performed with Stat View 5.0 software (SAS Insti-
tute Inc, Cary, NC).
RESULTS
Patient Characteristics
Therewere no significant differences between the 2 groups
for demographic data at the time of stage 1 Norwood proce-
dure (Table 1). Mean body weight at stage 1 Norwood proce-
durewas similar in both groups (2.6 0.3 kg vs 2.5 0.2 kg,
P ¼ .46). The mean age at stage 1 palliation was 7.5  2.6
days in group 1 and 6.5  3.4 days in group 2 (P ¼ .48).
No difference was observed for the presence of aortic atresia
with mitral stenosis (11%, 1/9 vs 27%, 3/11; P ¼ .36). The
incidence of restrictive atrial septal defect was 22% (2/9) in
group 1 and 18% (2/11) in group 2 (P ¼ .82). No patient in
either group had more than moderate tricuspid regurgitation.
Group 2 included 1 patient with Noonan syndrome and 1
patient with trisomy 21.
Early and Interstage Results
Operative data are summarized in Table 1. The cumula-
tive, 30-day, stage 1 mortality was 97% for all patients
(73/75). Thirty-day stage 1 survival in patients weighing
<3 kg was 88% (8/9) in group 1 and 90% (10/11) in
group 2 (P ¼ .88). Pulse oximetry oxygen saturation at
discharge was 91.8  3.2% in group 1 and 82.3 
4.7% in group 2 (P ¼ .0009). No patient in either group
developed severe ventricular dysfunction or arrhythmias
at discharge. One patient had severe ventricular dysfunc-
tion at interstage in group 2. All patients were placed on
an aspirin regimen postoperatively. There was no differ-
ence in the interstage mortality between the 2 groups
(12%, 1/8 vs 10%, 1/10; P ¼ .49), and 1 group 2 patient
with aortic atresia with mitral stenosis and left ventricular
sinusoids was referred for cardiac transplantation.
Angiotensin-converting enzyme inhibitors were prescribed
for 85% (6/7) in group 1 patients and 62% (5/8) in group
2 patients after stage 1 palliation (P ¼ .589).
Mid-Term Results
Themedian age atBCPSwas older in group1 patients (194
days; range, 104-693 days vs 111 days; range, 72-172 days;
P ¼ .028), but weight was similar in both groups (5.2  1.7
kg vs 4.9  0.3 kg, P ¼ .78; Table 2). Pulmonary/systemic
flow ratiowas 1.77 0.88 in group 1 and 1.06 0.39 in group
2 (P¼ .05). Ventricular end diastolic pressure was similar in
both groups (9 2mmHg vs 10 4mmHg,P¼ .60).Meangery c November 2012
TABLE 1. Demographic and perioperative data at stage 1 palliation
6-mm RV-PA
conduit (n ¼ 9)
5-mm RV-PA




Age at stage 1, d 7.5  2.6 6.5  3.4 .48
Weight at stage 1, kg 2.6  0.3 2.5  0.2 .46
Male/female 3/6 7/4 .11
AAwith MS 11% (1/9) 27% (3/11) .36
Restrictive ASD 22% (2/9) 18% (2/11) .82
Genetic syndrome 0% (0/9) 18% (2/11) .17
Preoperative data at stage 1 Norwood
Bypass time, min 113  27.4 116.9  33.8 .78
Crossclamp time, mn 41.2  12.8 53  11.5 .052
SpO2 at discharge,% 91.8  3.2 82.3  4.7 .0009
RV-PA, Right ventricle–pulmonary artery; AA, aortic atresia; MS, mitral stenosis;
ASD, atrial septal defect; SpO2, hemoglobin–oxygen saturation by pulse oximetry.
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Dcoronary perfusion pressure was higher in group 1 patients
(39 2mmHg vs 33 6mmHg, P¼ .026). Themean cen-
tral PA confluence size at pre-BCPS catheterization was 4.5
 1.2 mm in group 1 patients and 2.5  1.0 mm in group 2
patients (P ¼ .009). The diameter of the right PAwas 8.7 
2.7 mm in the 6-mm shunt group and 6.8  2.2 mm in the
5-mm shunt group (P ¼ .19). The diameter of the left PA
was 8.1  3.0 mm in the 6-mm shunt group and 6.2  3.1
mm in the 5-mm shunt group (P ¼ .30). PA index was
416.6  175.4 mm2/m2 in group 1 and 349.2  276.5 mm2/
m2 in group 2 (P¼ .63). The mean transpulmonary gradient
was higher in group 2 patients (7.8 3.1 vs 4.2 1.9mmHg,
P¼ .036). A balloon arterioplasty to the left PA in group 1TABLE 2. Pre-Glenn cardiac catheterization data and Glenn
operative data at stage 2
6-mm RV-PA
conduit (n ¼ 7)
5-mm RV-PA




Qp/Qs ratio 1.77  0.88 1.06  0.39 .05
Transpulmonary
gradient, mm Hg
4.2  1.9 7.8  3.1 .036
Ventricular end diastolic
pressure, mm Hg
9.4  2.9 10.5  4.1 .60
Coronary perfusion
pressure, mm Hg
39.8  2.9 33  6.3 .026
Minimum size of the
central PA, mm
4.5  1.2 2.5  1.0 .009
RPA, mm 8.7  2.7 6.8  2.2 .19
LPA, mm 8.1  3.0 6.2  3.1 .30
Nakata index, mm2/m2 416.6  175.4 349.2  276.5 .63
Shunt stenosis (PA site) 14.2% (1/7) 25% (2/8) .61
Operative data at Glenn
Age at Glenn, d 194 (104-693 ) 111 (72-172 ) .028
Weight at Glenn, kg 5.2  1.7 4.9  0.3 .78
Off-pump Glenn 100% (7/7) 0% (0/8) .0002
RV-PA, Right ventricle–pulmonary artery conduit; Qp/Qs, pulmonary-to-systemic
flow ratio; PA, pulmonary artery; RPA, right pulmonary artery; LPA, left pulmonary
artery.
The Journal of Thoracic and Carand a PA stent insertion to distal shunt stenosis in group 2
were performed. A left PA plasty and 5 bilateral PA plas-
ties in group 2 were done at stage 2 palliation. The inci-
dence of PA intervention (surgical or balloon arterioplasty
 PA stent insertion) was 16% (1/7) in group 1 and 75%
(6/8) in group 2 (P ¼ .030). All group 1 patients had
BCPS without cardiopulmonary bypass, whereas no group
2 patient could have an off-pump BCPS (P< .001). No
patient required tricuspid valve repair in either group.
The 30-day survival after BCPS was 100% (6/6) in group
1 and 87% (7/8) in group 2 (P ¼ .36). Survival rate at 6
months was 66% (6/9) in group 1 patients and 70% (7/
10) in group 2 patients (P ¼ .89). Neither group had
RV-PA conduit obstruction at the proximal insertion site
of the right ventricular infundibulum. Obstruction of the
RV-PA conduit at the distal insertion site of the conduit
into the PA bifurcation was identified in 1 group 1 patient
and 2 group 2 patients.
DISCUSSION
Modifications to surgical technique and perioperative
care have improved mortality and morbidity for patients
with HLHS and its variants. The RV-PA modification to
the Norwood procedure has become widely accepted as
an effective alternative to the Norwood procedure with
mBTS and represents an important development in surgi-
cal technique. The impact of the RV-PA conduit on PA
size has been reported. Rumball and associates16 have
shown that infants having the RV-PA modification of the
Norwood procedure have larger left PA dimensions com-
pared with those with the mBTS, but also have significant
central PA hypoplasia. Pruetz and colleagues19 have also
shown that the RV-PA conduit does result in significantly
larger distal left PA size and more evenly balanced branch
PA growth. However, there was a higher incidence of cen-
tral PA hypoplasia and the need for additional shunting or
early Glenn surgery. In a recent report by Griselli and co-
workers,15 the need to address central PA stenosis and
PA hypoplasia was 98% in their patients who underwent
the RV-PA Norwood procedure. We hypothesized origi-
nally that the 6-mm RV-PA conduit would result in im-
proved central PA growth and reduced PA intervention
compared with the 5-mm conduit. This study reports the
differences in PA growth between 2 sizes of RV-PA con-
duit. Use of the 6-mm RV-PA conduit is associated with
larger central PA size and had only 1 PA intervention.
The PA index in group 1 was not statistically larger than
group 2, possibly because of poststenotic dilation caused
by the narrow central PA in group 2. However, the higher
pulmonary blood flow in group 1 may have resulted in bet-
ter development of the central and peripheral PA vessels,
and may have led to a lower transpulmonary gradient.
The larger central PA in group 1 decreased the need for
PA augmentation before and during the Glenn operation.diovascular Surgery c Volume 144, Number 5 1093
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DInfants having the 5-mm RV-PA conduit were referred for
Glenn surgery, on average, more than 2 months earlier than
those in group 1. Moreover, group 1 patients were better
suited for BCPS without cardiopulmonary bypass. Major
evolution of the RV-PA conduit was in the site of the right
ventriculotomy, whichmoved cephalad and leftward as our
experience evolved between 2002 and 2010. Era effect
probably plays a role; however, the anatomy of the PA is
a more important determinant not to use cardiopulmonary
bypass. A recent report from our institution18 showed that
BCPS without the use of cardiopulmonary bypass can be
performed safely and with low mortality and less blood
product usage in select infants with HLHS.
Recent advances have led to improved operative out-
comes in HLHS and its variants, and we hope this study
will advance the surgical strategies for selection of optimal
shunt sizes as to decrease PA intervention rate and favor the
use of off-pump BCPS. The differences in PA growth might
affect long-term Fontan outcomes.Limitations
The limitations of this report include its retrospective ob-
servational nature and relatively small numbers. This study
is not powered to evaluate long-term outcome for PA size
and ventricular function between comparison groups. The
ongoing randomized trial, ideally, will resolve many of
these questions and avoidmany of the limitations associated
with retrospective studies.CONCLUSIONS
Satisfactory 30-day survival and interstage mortality af-
ter stage 1 reconstruction can be achieved with a 6-mm of
RV-PA conduit. The 6-mm conduit promotes central PA
growth, an improved transpulmonary gradient, and less
need for PA intervention and higher success of off-pump
BCPS without hospital death.References
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